Strong IgG antibody responses to Borrelia burgdorferi glycolipids in patients with Lyme arthritis, a late manifestation of the infection

Clinical Immunology

Volumn 132, Issue 1, 2009, Pages 93-102

  Jones, Kathryn L ^a   Seward, Robert J ^a,c   Ben Menachem, Gil ^b   Glickstein, Lisa J ^a   Costello, Catherine E ^c   Steere, Allen C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibodies; ; Bacterial infection; ; Borrelia burgdorferi; ; Glycolipid antigens; Lyme disease;

Indexed keywords

ANTIBIOTIC AGENT; CHOLESTEROL ESTER; GALACTOSIDE; GALACTOSYLDIACYLGLYCEROL; GLYCOLIPID; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY RESPONSE; ARTICLE; BORRELIA BURGDORFERI; BORRELIA INFECTION; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA CHRONICUM MIGRANS; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; LYME DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROLOGY;

ANTIBODIES, BACTERIAL; BORRELIA BURGDORFERI; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOLIPIDS; HUMANS; IMMUNOGLOBULIN G; LYME DISEASE; MEMBRANE LIPIDS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 67349224063     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.03.510     Document Type: Article

References (29)

1. Steere A.C. Lyme disease. New Engl. J. Med. 345 (2001) 115-125
2. Akin E., McHugh G.L., Flavell R.A., Fikrig E., and Steere A.C. The immunoglobulin (IgG) antibody response to OspA and OspB correlates with severe and prolonged Lyme arthritis and the IgG response to P35 correlates with mild and brief arthritis. Infect. Immun. 67 (1999) 173-181
3. Dressler F., Whalen J.A., Reinhardt B.N., and Steere A.C. Western blotting in the serodiagnosis of Lyme disease. J. Infect. Dis. 167 (1993) 392-400
4. Barbour A.G., Jasinskas A., Kayala M.K., Davies D.H., Steere A.C., Baldi P., and Felgner P.L. A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect. Immun. 76 (2008) 3374-3389
5. Nowalk A.J., Gilmore Jr. R.D., and Carroll J.A. Serologic proteome analysis of Borrelia burgdorferi membrane-associated proteins. Infect. Immun. 74 (2006) 3864-3873
6. Fikrig E., Barthold S.W., Chen M., Chang C.H., and Flavell R.A. Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells. J. Immunol. 159 (1997) 5682-5686
7. Kannian P., McHugh G., Johnson B.J., Bacon R.M., Glickstein L.J., and Steere A.C. Antibody responses to Borrelia burgdorferi in patients with antibiotic-refractory, antibiotic-responsive, or non-antibiotic-treated Lyme arthritis. Arthritis Rheum. 56 (2007) 4216-4225
8. Heikkilä T., Huppertz H.-I., Seppälä I., Sillanpää H., Saxen H., and Lahdenne P. Recombinant or peptide antigens in the serology of Lyme arthritis in children. J. Infect. Dis. 187 (2003) 1888-1894
9. Wheeler C.M., Garcia Monco J.C., Benach J.L., Golightly M.G., Habicht G.S., and Steere A.C. Nonprotein antigens of Borrelia burgdorferi. J. Infect. Dis. 167 (1993) 665-674
10. Hossain H., Wellensiek H.J., Geyer R., and Lochnit G. Structural analysis of glycolipids from Borrelia burgdorferi. Biochimie 83 (2001) 683-692
11. Livermore B.P., and Johnson R.C. Lipids of the Spirochaetales: comparison of the lipids of several members of the genera Spirochaeta, Treponema, and Leptospira. J. Bacteriol. 120 (1974) 1268-1273
12. Ben-Menachem G.J., Kubler-Kielb J., Coxon B., Yergey A., and Schneerson R. A newly discovered cholesteryl galactoside from Borrelia burgdorferi. Pro. Nat. Acad. Sci. U.S.A. 100 (2003) 7913-7918
13. Schroder N.W., Schombel U., Heine H., Gobel U.B., Zahringer U., and Schumann R.R. Acylated cholesteryl galactoside as a novel immunogenic motif in Borrelia burgdorferi sensu stricto. J. Biol. Chem. 278 (2003) 33645-33653
14. CDC. Case definitions for public health surveillance. MMWR Morb. Mort. Wkly. Rpt. 39 (1990) 1-43
15. CDC. Recommendations for test performance and interpretation from the Second International Conference on serologic diagnosis of Lyme disease. MMWR Morb. Mort. Wkly. Rpt. 44 (1995) 590-591
16. Aguero-Rosenfeld M.E., Nowakowski J., Bittker S., Cooper D., Nadelman R.B., and Wormser G.P. Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J. Clin. Microbiol. 34 (1996) 1-9
17. Steere A.C., McHugh G., Damle N., and Sikand V.K. Prospective study of serologic tests for Lyme disease. Clin. Infect. Dis. 47 (2008) 188-195
18. Jones K.L., Glickstein L.J., Damle N., Sikand V.K., McHugh G., and Steere A.C. Borrelia burgdorferi genetic markers and disseminated disease in patients with early Lyme disease. J. Clin. Microbiol. 44 (2006) 4407-4413
19. Steere A.C., and Angelis S.M. Therapy for Lyme arthritis; strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum. 54 (2006) 3079-3085
20. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Med. Sci. 37 (1959) 911-917
21. Pozsgay V., and Kubler-Kielb J. Synthesis of an experimental glycolipoprotein vaccine against Lyme disease. Carbohydrate Res. 342 (2007) 621-626
22. Nocton J.J., Dressler F., Rutledge B.J., Rys P.N., Persing D.H., and Steere A.C. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N. Engl. J. Med. 330 (1994) 229-234
23. 6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease. J. Infect. Dis. 187 (2003) 1178-1186
24. Sears J.E., Fikrig E., Nakagawa T.Y., Deponte K., Marcantonio N., Kantor F.S., and Flavell R.A. Molecular mapping of OspA-mediated immunity against Borrelia burgdorferi, the agent of Lyme disease. J. Immunol. 147 (1991) 1995-2000
25. Leadbetter E.A., Brigl M., Illarionov P., Cohen N., Luteran M.C., Pillai S., Besra G.S., and Brenner M.B. NK T cells provide lipid antigen-specific cognate help for B cells. Proc. Nat. Acad. Sci. U. S. A. 105 (2008) 8339-8344
26. Kinjo Y., Tupin E., Wu D., Fujio M., Garcia-Navarro R., Benhnia M.R., Zajonc D.M., Ben-Menachem G., Ainge G.D., Painter G.F., Khurana A., Hoebe K., Behar S.M., Beutler B., Wilson I.A., Tsuji M., Sellati T.J., Wong C.H., and Kronenberg M. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7 (2006) 978-986
27. De Bruijn J.H. Chemical structure and serological activity of natural and synthetic cardiolipin and related compounds. Br. J. Venereal Dis. 42 (1966) 125-128
28. Steere A.C., Sikand V.K., Meurice F., Parenti D.L., Fikrig E., Schoen R.T., Nowakowski J., Schmid C.H., Laukamp S., Buscarino C., and Krause D.S. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface protein A with adjuvant. N. Engl. J. Med. 339 (1998) 209-215
29. Sigal L.H., Zahradnik J.M., Lavin P., Patella S.T., Bryant G., Haselby R., Hilton E., Kunkel M., Adler-Klein D., Doherty T., Evans J., Molloy P.J., Seidner A.L., Sabetta J.R., Simon H.J., Klempner M.S., Mays J., Marks D., and Malawista S.E. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant outer-surface protein A Lyme disease vaccine study. N. Engl. J. Med. 339 (1998) 216-222